Table 1.

Patient characteristics and procedure details.

Characteristics (n = 88 Patients, n = 285 ERCP Procedures)
Sex, female, absolute (%)	27 (30.7)
Age at time of ERCP, years, median (min./max.)	56 (21/77)
Period from transplant to ERCP, month, median (min./max.)	17 (0/226)
Length of hospital stay, days, median (min./max.)	4 (2/23)
Biliodigestive anastomosis, absolute (%)	6 (6.8)
MDR colonization, absolute (%)	42 (47.7)
Indication for liver transplantation, absolute (%)
Alcoholic liver cirrhosis	16 (18.2)
Primary sclerosing cholangitis	15 (17.0)
Non-alcoholic steatohepatitis	12 (13.6)
Hepatocellular carcinoma	12 (13.6)
Cryptogen	9 (10.2)
Medicinal/toxic	5 (5.7)
Autoimmune hepatitis	5 (5.7)
Viral hepatitis	4 (4.5)
Wilson’s disease	4 (4.5)
Primary biliary cirrhosis	2 (2.3)
Amyloidosis	1 (1.1)
Cholangiocellular carcinoma	1 (1.1)
Heterozygous Alpha-1-Antitrypsin-Deficiency	1 (1.1)
Budd Chiari	1 (1.1)
Immunosuppressive therapy at time of ERCP, absolute (%)
Mycophenolate mofetil	163 (57.2)
Tacrolimus	237 (83.2)
Prednisolone	26 (9.1)
Cyclosporine	24 (8.4)
Sirolimus	14 (4.9)
Everolimus	77 (26.9)